Exam 3: MH701 MH 701 Latest

Exam 3: MH701 / MH 701 (Latest

Update 2025 / 2026) Psychopharmacologic / Neuroscience Foundations of Mental Health Care | Review Questions and Answers | 100% Correct - Frontier

Question:

Psychopharmacology in pediatrics:

Answer:

• A large percentage of psychotropic medications have not been adequately

studies in youth, many of these compounds do not have FDA approval indications for pediatric patients.

• Medications are frequently used "off label" in children and adolescents.
• The FDA does not regulate provider prescribing practice and therefore does

not prohibit the off-label use of medication.

• However, as FDA approved indications are generally the result of

methodologically stringent evidence, clinicians should first consider FDA approved medication options whenever available and feasible.

• / 4

Question:

Ethical issues in pediatric pharmacology:

Answer:

• Since children and adolescents are particularly vulnerable population,

certain ethical principles guide the practice of pediatric

psychopharmacotherapy. These include:

• Obtaining informed consent and assent prior to prescribing psychotropic

mediations.

• Continuing discussions with the patient and family about the treatment

option.

Question:

Informed consent and assent:

Answer:

• As treatment options are presented to the patient and parents, the clinician

provides education to help the family understand the purpose of the treatment option.

• This initiates both an informed consent process with the parents and an

assent process with the patient that generally occur before beginning psychopharmacologic Rx.

• / 4

Question:

Informed consent:

Answer:

Initiate or continue a psychotropic medication generally requires the patient's parents to be competent, to demonstrate adequate knowledge about the proposed medication, and to make the treatment decision freely without coercion.

Question:

Adequate knowledge:

Answer:

About a psychotropic medication usually includes an understanding of the nature of the patient's psychiatric disorder, the potential risks, benefits an side effects of the proposed rx, the possible alternatives to the proposed rx, and the patients expected prognosis both with and without the proposed rx.

Question:

Children provide informed assent

Answer:

Generally requires a child to demonstrate an age=appropriate awareness of the psychiatric dx and both an understanding and acceptance of the recommended Rx.

• / 4

Question:

Psychostimulants: used for: how they work:

Answer:

• Increased mood, energy, and wakefulness.
• Called sympathomimetics because they increase physiologic effect of

neurotransmitter epinephrine.

• Most commonly used to treat ADS.
• Classified as controlled due to rapid onset, immediate behavior effects and

propensity to develop tolerance.

• Also used in narcolepsy.
• Have been used in cognitive disorders that result in secondary depression

or profound apathy,, MS, post-stroke depression and dementia, and augmentation or antidepressants in treatment resistant depression.

Question:

Pharmacological action: Amphetamine:

Answer:

• Increase central DA & NE activity, which impact executive and attention

function.

• Increases DA release across multiple brain region, including the dorsal and

ventral striatum, substantia nigra and regions of the cortex.

• Amphetamine, ( Adderall) and dextroamphetamine (Dexedrine), reach

peak plasma concentrations in 2-3 hours and have a half-life of about 6 hours.

• / 4